Treatment and Outcome of Adult-onset Neuroblastoma
Overview
Authors
Affiliations
Adult-onset neuroblastoma is rare and little is known about its biology and clinical course. There is no established therapy for adult-onset neuroblastoma. Anti-GD2 immunotherapy is now standard therapy in children with high-risk neuroblastoma; however, its use has not been reported in adults. Forty-four adults (18-71 years old) diagnosed with neuroblastoma between 1979 and 2015 were treated at Memorial Sloan Kettering Cancer Center. Five, 1, 5 and 33 patients had INSS stage 1, 2, 3 and 4 diseases, respectively. Genetic abnormalities included somatic ATRX (58%) and ALK mutations (42%) but not MYCN-amplification. In the 11 patients with locoregional disease, 10-year progression-free (PFS) and overall survival (OS) was 35.4 ± 16.1% and 61.4 ± 15.3%, respectively. Among 33 adults with stage 4 neuroblastoma, 7 (21%) achieved complete response (CR) after induction chemotherapy and/or surgery. Seven patients with primary refractory neuroblastoma (all with osteomedullary but no soft tissue disease) received anti-GD2 antibodies, mouse or humanized 3F8. Antibody-related adverse events were similar to those in children, response rate being 71.4%. In patients with stage 4 disease at diagnosis, 5-year PFS was 9.7± 5.3% and most patients who were alive with disease at 5 years died of neuroblastoma over the next 5 years, 10-year OS being only 19.0 ± 8.2%. Patients who achieved CR after induction had superior PFS and OS (p = 0.006, p = 0.031, respectively). Adult-onset neuroblastoma appeared to have different biology from pediatric or adolescent NB, and poorer outcome. Complete disease control appeared to improve long-term survival. Anti-GD2 immunotherapy was well tolerated and might be beneficial.
Adult-onset pancreatic neuroblastoma: A case report with a literature review.
Alshadood N, Aldarawsha A, Al-Badri S, Elazab M, Mahdi M, Yousif F Radiol Case Rep. 2024; 20(1):539-544.
PMID: 39559503 PMC: 11570904. DOI: 10.1016/j.radcr.2024.10.066.
Metanephrine mirage: distinguishing the phaeocopies, a case report and literature review.
Gong J, Gordon D, Ye S, Fleming B, Tan J, Hulf T Clin Diabetes Endocrinol. 2024; 10(1):37.
PMID: 39548528 PMC: 11568592. DOI: 10.1186/s40842-024-00198-1.
An Unusual Occurrence of Metastases to Multiple Muscles in Neuroblastoma.
Khan D, Sagar S, Shamim S, Kaushik P, Kumar R Indian J Nucl Med. 2024; 39(3):222-223.
PMID: 39291061 PMC: 11404728. DOI: 10.4103/ijnm.ijnm_37_23.
Collins K, Ulbright T, Davis J Diagn Pathol. 2023; 18(1):127.
PMID: 38031161 PMC: 10685643. DOI: 10.1186/s13000-023-01417-6.
Anaplastic Lymphoma Kinase Inhibitors for Therapy of Neuroblastoma in Adults.
Stiefel J, Kushner B, Roberts S, Iglesias-Cardenas F, Kramer K, Modak S JCO Precis Oncol. 2023; 7:e2300138.
PMID: 37561984 PMC: 10581627. DOI: 10.1200/PO.23.00138.